ABBV: AbbVie Inc
ABBV exchange rate has changed by -1.48% for today. During the day, the instrument was traded at a low of 255.61 and at a high of 258.91.
Follow AbbVie Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
ABBV News
- Lilly (LLY) Down 2.7% Since Last Earnings Report: Can It Rebound?
- ABBV's Etentamig Meets Goals in Phase III Multiple Myeloma Study
- The Zacks Analyst Blog Highlights Amazon.com, AbbVie, Alibaba and Lulu's Fashion Lounge
- AbbVie: Shares Defy Sell-Side Downgrades, And That's Bullish (ABBV)
- Top Analyst Reports for Amazon, AbbVie & Alibaba
- AbbVie Touts Positive Data For Multiple Myeloma Drug - AbbVie (NYSE:ABBV)
- Pfizer (PFE) Up 12.4% Since Last Earnings Report: Can It Continue?
- ABBV Stock Trading Above 50- & 200-Day SMAs: Buy, Hold or Sell?
- 5 Reasons To Buy Clinuvel Pharmaceuticals After Its Nasdaq Uplisting (NASDAQ:CUVL)
- Can LLY's Merida Deal Boost Its M&A Push to Diversify Beyond GLP-1s?
- JNJ Replaced $913 Million In Lost Sales With $2.4B In New Ones - But Kept Less Than Half
- GSK Stock Down 14% in Six Months: Time to Buy, Hold or Exit?
- Trump Admin To Target Biotechs With Curbs On Drug Pricing? What Investors Should Know
- Aging Population Drives Healthcare Growth: Stocks to Watch
- How Is AbbVie’s Stock Performance Compared to Other Healthcare Stocks
- AbbVie Seeks EU Nod for Subcutaneous Skyrizi in Crohn's Disease
- FDA Nods Lilly-Roche's Alzheimer's Blood Test: Healthcare ETFs to Track Now
- TG Therapeutics: Briumvi's Peak May Be Far Away (Rating Upgrade) (NASDAQ:TGTX)
- How Did ABBV's Oncology Sales Hold Up in Q2 Amid Imbruvica Headwinds?
- LLY vs. ABBV: Which Stock Has the Stronger Growth Prospects?
- RGNX Stock Slumps 25% on FDA Clinical Hold for RGX-121 Gene Therapy
- AbbVie Still Has Room To Run (NYSE:ABBV)
- Is SYRE a Buy Now as Clinical Catalysts Clash With Valuation Risk?
- Can Spyre's SPY772 HS Study Broaden Its Growth Story Beyond Core IBD?
Frequently Asked Questions
What is ABBV stock price today?
AbbVie Inc stock is priced at 256.37 today. It trades within 255.61 - 258.91, yesterday's close was 260.21, and trading volume reached 6470. The live price chart of ABBV shows these updates.
Does AbbVie Inc stock pay dividends?
AbbVie Inc is currently valued at 256.37. Dividend policy depends on the company, while investors also watch 9.95% and USD. View the chart live to track ABBV movements.
How to buy ABBV stock?
You can buy AbbVie Inc shares at the current price of 256.37. Orders are usually placed near 256.37 or 256.67, while 6470 and -0.60% show market activity. Follow ABBV updates on the live chart today.
How to invest into ABBV stock?
Investing in AbbVie Inc involves considering the yearly range 191.00 - 267.47 and current price 256.37. Many compare -1.68% and 17.32% before placing orders at 256.37 or 256.67. Explore the ABBV price chart live with daily changes.
What are AbbVie Inc stock highest prices?
The highest price of AbbVie Inc in the past year was 267.47. Within 191.00 - 267.47, the stock fluctuated notably, and comparing with 260.21 helps spot resistance levels. Track AbbVie Inc performance using the live chart.
What are AbbVie Inc stock lowest prices?
The lowest price of AbbVie Inc (ABBV) over the year was 191.00. Comparing it with the current 256.37 and 191.00 - 267.47 shows potential long-term entry points. Watch ABBV moves on the chart live for more details.
When did ABBV stock split?
AbbVie Inc has gone through stock splits historically. These changes are visible in , 260.21, and 9.95% after corporate actions.
- Previous Close
- 260.21
- Open
- 257.93
- Bid
- 256.37
- Ask
- 256.67
- Low
- 255.61
- High
- 258.91
- Volume
- 6.470 K
- Daily Change
- -1.48%
- Month Change
- -1.68%
- 6 Months Change
- 17.32%
- Year Change
- 9.95%